• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

The Promise of Individualized Treatment for Cancer: How Individualized Neoantigen Therapy (INT) Will Change Oncology

Wednesday, June 05, 2024
Breakout Session
Oncology
26A
Producing a bespoke medicine to target the unique tumor characteristics of each patient offers much promise and could be a game changer in how we treat cancer. However, bringing INT medicines to individuals in need will require addressing a broad set of new challenges for a diverse group of health system stakeholders. This panel will explain what INT is, introduce some of the unique challenges and opportunities it presents and discuss potential solutions needed to bring the promise of INT to patients.
Speakers
Scot Ebbinghaus
Vice President
Merck

Sponsored by:

merck logo

Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS